Belmora LLC v. Bayer Consumer Care AG
United States Court of Appeals for the Fourth Circuit
819 F.3d 697 (2016)
- Written by Sean Carroll, JD
Facts
Bayer Consumer Care AG (Bayer) (plaintiff) owned a trademark for “FLANAX” in Mexico. Bayer used the mark beginning in the 1970s. Belmora LLC owned a trademark for “FLANAX” in the United States. Belmora used the mark beginning in 2004. Both parties used their marks to sell pain relievers. Belmora heavily marketed its pain reliever to Mexican Americans, and made statements intimating an association with Bayer’s Flanax such as “Flanax is now made in the U.S.” Bayer petitioned the Trademark Trial and Appeal Board for cancellation of Belmora’s mark. The board granted the petition. Belmora appealed the decision to the district court. Bayer also separately sued Belmora for false association and false advertising under section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a). The cases were consolidated in the United States District Court for the Eastern District of Virginia. The district court reversed the board’s decision and granted Belmora’s motion to dismiss. The district court ruled that an owner of a foreign trademark that has not used the mark in commerce in the U.S. cannot assert priority over another party’s mark that is used in commerce in the U.S. Bayer appealed.
Rule of Law
Issue
Holding and Reasoning (Agee, J.)
What to do next…
Here's why 812,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.